Stock GYRE GYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

End-of-day quote Nasdaq
Other stock markets
 23:00:00 13/06/2024 BST 		5-day change 1st Jan Change
11.04 USD 0.00% Intraday chart for Gyre Therapeutics, Inc. -0.45% -57.03%
05-31 Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy MT
05-30 Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy
Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing
Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises
Gyre Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Gyre Therapeutics Announces Appointment of Rodney L. Nussbaum to the Board of Directors and Member of Audit Committee
Gyre Therapeutics, Inc. Announces Board Changes
Gyre Therapeutics, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Gyre Therapeutics, Inc. Announces CEO Changes, Effective January 15, 2024
Gyre Therapeutics, Inc. and Beijing Continent Pharmaceuticals Co., Ltd. Announce the Resignation of Charles Wu as Member of the Board of Directors. Effective on January 15, 2024
Gyre Therapeutics, Inc. Announces Management Changes
Gyre Therapeutics, Inc. Announces Management Changes
Gyre Therapeutics, Inc. Announces CEO Changes
Gyre Therapeutics, Inc. Announces Management Changes
Gyre Therapeutics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GYRE Stock
  4. News Gyre Therapeutics, Inc.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW